Cryolife, Inc. (CRY) Receives CE Mark for BioGlue Surgical Adhesive for European Market
Cryolife, Inc. (CRY), headquartered in both Atlanta, Georgia and San Mateo, California, processes and distributes implantable living human tissues for use in cardiac and vascular surgeries throughout the United States and Canada. The company recently announced the receipt of a CE Mark for the use of CryoLife’s BioGlue Surgical Adhesive for periosteal fixation following a brow lift. The CE Mark approval is a visible declaration by the manufacturer or representative that the equipment complies with all the requirements of the applicable European Union (EU) directives. The adhesive will be distributed by the company’s partner, BioForm Medical, for use in approved…